Tramadol hydrochloride/montmorillonite composite: Preparation and controlled drug release

Applied Clay Science

Volumn 49, Issue 3, 2010, Pages 108-112

  Chen, Youmei ^a   Zhou, Anning ^a   Liu, Bo ^a   Liang, Jun ^a  

^a XI'AN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adsorption; Controlled drug release; Intercalation; Montmorillonite; Tramadol hydrochloride

Indexed keywords

BASAL SPACING; CONTROLLED DRUG RELEASE; CONTROLLED DRUG RELEASE SYSTEMS; CONTROLLED RELEASE; FTIR; GASTRIC FLUIDS; INTESTINAL FLUID; LANGMUIR MODELS; MONTMORILLONITE; PSEUDO SECOND ORDER KINETICS; TRAMADOL; TRAMADOL HYDROCHLORIDE; XRD;

CLAY MINERALS; SILICATE MINERALS;

ADSORPTION;

ADSORPTION; COMPOSITE; DRUG; EXPERIMENTAL MINERALOGY; FTIR SPECTROSCOPY; ISOTHERM; MONTMORILLONITE; NUMERICAL MODEL; PREFERRED ORIENTATION; REACTION KINETICS; SAMPLE PREPARATION; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 77955057620     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2010.04.011     Document Type: Article

References (15)

1. Ambrogi V., Fardella G., Grandolini G., Perioli L. Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents. I. Intercalation and in vitro release of ibuprofen. Int. J. Pharm. 2001, 220(1-2):23-32.
2. Bergaya F., Theng B.K.G., Lagaly G. Handbook of Clay Science 2006, Elsevier, Amsterdam.
3. Brophy M.R., Deasy P.B. Application of the Higuchi model for drug release from dispersed matrices to particles of general shape. Int. J. Pharm. 1987, 37(1-2):41-47.
4. Carretero M.I. Clay minerals and their beneficial effects upon human health. Appl. Clay Sci. 2002, 21(3):155-163.
5. Ho Y.S., McKay G. Pseudo-second order model for sorption processes. Process Biochem. 1999, 34(5):451-465.
6. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int. J. Pharm. 2009, 374(1-2):53-57.
7. Joshi G.V., Patel H.A., Kevadiya B.D., Bajaj H.C. Montmorillonite intercalated with vitamin B1 as drug carrier. Appl. Clay Sci. 2009, 45(4):248-253.
8. Langmuir The constitution and fundamental properties of solids and liquids. J. Am. Chem. Soc. 1916, 38(11):2221-2295.
9. Lebitasy M., Hecq J.D., Vanbeckbergen D., Jamart J., Galanti L. Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5±3°C. Ann. Pharm. Fr. 2009, 67(4):272-277.
10. Meng N., Zhou N., Zhang S., Shen J. Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite. Int. J. Pharm. 2009, 382(1-2):45-49.
11. Park J.K., Choy Y.B., Oh J., Kim J.Y., Hwang S., Choy J. Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm. 2008, 359(1-2):198-204.
12. Ritger P.L., Peppas N.A. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Contr. Release 1987, 5(1):37-42.
13. Sun B., Ranganathan B., Feng S. Multifunctional poly(d, l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008, 29(4):475-486.
14. Suzuki N., Nakamura Y., Watanabe Y., Kanzaki Y.K. Intercalation compounds of layered materials for drug delivery use. II. Diclofenac sodium. Chem. Pharm. Bull. 2001, 49(8):964-968.
15. Zheng J.P., Luan L., Wang H.Y., Xi L.F., Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl. Clay Sci. 2007, 36(4):297-301.